Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Acta Neurologica Scandinavica. Supplementum
|
June 18, 2008
The cuprizone model for demyelination
O Torkildsen, L A Brunborg, K-M Myhr, et al.
Acta Neurologica Scandinavica. Supplementum
|
April 28, 2006
FcgammaR and multiple sclerosis: an overview
O Torkildsen, C A Vedeler, H I Nyland, et al.
Acta Neurologica Scandinavica. Supplementum
|
January 3, 2013
Month of birth as a risk factor for multiple sclerosis: an update
O Torkildsen, N Grytten, J Aarseth, et al.
Scandinavian Journal of Immunology
|
August 11, 2005
Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population
O Torkildsen, E Utsi, H F Harbo, et al.
Journal of Neuroimmunology
|
July 9, 2005
High dose methylprednisolone induces FcgammaRI on granulocytes in MS-patients
O Torkildsen, C A Vedeler, E Ulvestad, et al.
Multiple Sclerosis and Related Disorders
|
October 6, 2024
The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis
E Coerver, L Schoof, L Hogenboom, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Acta Neurologica Scandinavica. Supplementum
|
June 18, 2008
The cuprizone model for demyelination
O Torkildsen, L A Brunborg, K-M Myhr, et al.
Acta Neurologica Scandinavica. Supplementum
|
April 28, 2006
FcgammaR and multiple sclerosis: an overview
O Torkildsen, C A Vedeler, H I Nyland, et al.
Acta Neurologica Scandinavica. Supplementum
|
January 3, 2013
Month of birth as a risk factor for multiple sclerosis: an update
O Torkildsen, N Grytten, J Aarseth, et al.
Scandinavian Journal of Immunology
|
August 11, 2005
Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population
O Torkildsen, E Utsi, H F Harbo, et al.
Journal of Neuroimmunology
|
July 9, 2005
High dose methylprednisolone induces FcgammaRI on granulocytes in MS-patients
O Torkildsen, C A Vedeler, E Ulvestad, et al.
Multiple Sclerosis and Related Disorders
|
October 6, 2024
The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis
E Coerver, L Schoof, L Hogenboom, et al.
Page
of 1